In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development. Science and ...

The deep integration of computer-aided drug discovery (CADD) and artificial intelligence (AI) is ushering in a new era of ...

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA's ...

In modern drug discovery, successfully navigating the progress from molecular concept to viable therapeutic often hinges on ...

Eli Lilly and Co (NYSE:LLY) has entered into a drug discovery collaboration with Insilico Medicine, a clinical-stage ...

The future of the global success story of the discovery of small molecule antibiotics, their evolution into viable drug therapies, and their application in ...

Bio (NASDAQ:IBIO) is seeking to narrow what it views as a growing “trust gap” between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market, ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma. Biotech uses AI for breakthrough discovery, while large pharma scales it to ...

Since 2008, Labroots has used its virtual events to connect a global network of scientists regarding the latest advancements in their fields. These virtual events include structured poster discussion ...

Lilly licenses Insilico's AI drug discovery platform in a deal worth up to $2.75B, signaling a shift in how novel ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10th Annual Drug Discovery & Development Virtual Event on February ...

In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...